United States· US:61269-565_45add4e4-7806-4a6c-b360-e6e383d7e18e

ORLISTAT

A orlistat product containing orlistat, registered in United States by H2-Pharma LLC. The same ATC class is registered in 16 of our 19 countries.

ATC A08AB01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedORLISTATATCA08AB01REGISTER NO.US:61269-565_45add4e4…PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Orlistat is registered in 16 of 19 countries.

Countries holding a registration under ATC A08AB01 (orlistat), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose

Orlistat · ATC A08AB01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of orlistat costs, country by country.

Normalised to the WHO defined daily dose (0.36 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Orlistat · price per daily dose (0.36 g)

USD · FX 28 Sept 2026

  • CH Switzerland$3.08
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ORLISTAT
Manufacturer
H2-Pharma LLC
Country
United States (US)
ATC code
A08AB01
ATC class
Orlistat
Defined daily dose
0.36 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    61269-565-90
  • ndc11
    6126956590
    90 CAPSULE in 1 BOTTLE, PLASTIC (61269-565-90)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

374 interactions on record for orlistat.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Orlistat · interactions on record

374 records

  • 9 severe
  • 117 moderate
  • 8 minor
  • 238 info

Most severe, free to view

  • TriheptanoinA16AX17severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • PexidartinibL01EX15severe

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Orlistat in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All orlistat products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Belgium · Orlistat Sandoz, Orlistat Teva
  • Czechia · Orlistat 1 A Pharma, Orlistat Sandoz
  • Germany · Orlistat 1 A Pharma, Orlistat Hexal
  • Denmark · Orlistat Accord, Orlistat Rivopharm
  • Estonia · Orlistat Sandoz
  • Spain · Beacita, Elimens
  • Finland · Orlistat Sandoz, Orlistat Stada
  • France · Orlistat Eg
  • United Kingdom (Northern Ireland) · Orlistat, Orlistat Accord-Uk
  • Ireland · Orlistat Accord
  • Iceland · Alli, Xenical
  • Italy · Beacita
  • Liechtenstein · Alli, Xenical
  • Lithuania · Orlistat Polpharma
  • Latvia · Orlistat Polpharma
  • Netherlands · Orlistat Sandoz
  • Norway · Alli, Orlistat Accord
  • Portugal · Orlistato Beacita, Orlistato Ciclum
  • Sweden · Beacita, Orlistat Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b17e0f7b-19ff-4378-9dc4-46b83b2b4d79
GET /v1/drugs/b17e0f7b-19ff-4378-9dc4-46b83b2b4d79?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "120",
  "substance": "ORLISTAT",
  "productndc": "61269-565",
  "dosage_form": "CAPSULE",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA020766",
  "marketing_category": "NDA AUTHORIZED GENERIC"
}

See everything about orlistat.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.